• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.37% Nasdaq Up0.33%

    Biogen Inc. (BIIB)

    -NasdaqGS
    390.78 Up 3.16(0.82%) 10:09AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 2,554,963   2,640,675   2,511,446   2,421,452  
    Cost of Revenue312,431  297,265  302,639  291,887  
    Gross Profit 2,242,532   2,343,410   2,208,807   2,129,565  
    Operating Expenses
    Research Development460,549  500,091  417,174  447,273  
    Selling General and Administrative568,205  580,930  521,003  580,641  
    Non Recurring -   -   -   -  
    Others95,903  107,246  122,431  116,826  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 1,117,875   1,159,763   1,152,578   988,725  
    Income from Continuing Operations
    Total Other Income/Expenses Net(14,986)(4,131)(11,911)8,761  
    Earnings Before Interest And Taxes1,102,889  1,155,632  1,140,667  997,486  
    Interest Expense -   -   -   -  
    Income Before Tax1,102,889  1,155,632  1,140,667  997,486  
    Income Tax Expense281,881  268,233  274,774  268,521  
    Minority Interest2,367  879  738  (8,626)
    Net Income From Continuing Ops822,541  888,084  861,237  718,406  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 822,541   883,464   856,858   714,506  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 822,541   883,464   856,858   714,506  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.